Skip to main content
Veterinary Medicines

Avishield ND B1, lyophilisate for oculonasal suspension/use in drinking water for Chickens

Authorised
  • Newcastle disease virus, strain B1 Hitchner, Live

Product identification

Medicine name:
Avishield ND B1, lyophilisate for oculonasal suspension/use in drinking water for Chickens
Avishield ND B1 vakcina A.U.V.
Active substance:
  • Newcastle disease virus, strain B1 Hitchner, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use
  • Oral use

Product details

Active substance and strength:
  • Newcastle disease virus, strain B1 Hitchner, Live
    6.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
  • Oral use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • Carton with 10 vials of 1000 doses of vaccine. Colourless glass vials (type I), which are closed with brombutyl rubber stoppers and sealed with aluminium caps.
  • Carton with 10 vials of 5000 doses of vaccine. Colourless glass vials (type I), which are closed with brombutyl rubber stoppers and sealed with aluminium caps.
  • Carton with 10 vials of 2500 doses of vaccine. Colourless glass vials (type I), which are closed with brombutyl rubber stoppers and sealed with aluminium caps.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • National Food Chain Safety Office
Authorisation number:
  • 3952/X/18 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0293/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Czechia
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."